nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP1A2—Sorafenib—thyroid cancer	0.159	0.248	CbGbCtD
Cyclobenzaprine—CYP3A4—Vandetanib—thyroid cancer	0.138	0.215	CbGbCtD
Cyclobenzaprine—CYP2D6—Sorafenib—thyroid cancer	0.131	0.204	CbGbCtD
Cyclobenzaprine—CYP3A4—Sorafenib—thyroid cancer	0.0833	0.13	CbGbCtD
Cyclobenzaprine—CYP2D6—Doxorubicin—thyroid cancer	0.0795	0.124	CbGbCtD
Cyclobenzaprine—CYP3A4—Doxorubicin—thyroid cancer	0.0505	0.0788	CbGbCtD
Cyclobenzaprine—Pollakiuria—Vandetanib—thyroid cancer	0.00456	0.0127	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00441	0.0123	CcSEcCtD
Cyclobenzaprine—Stomatitis—Vandetanib—thyroid cancer	0.00429	0.012	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Vandetanib—thyroid cancer	0.00353	0.00984	CcSEcCtD
Cyclobenzaprine—Alopecia—Vandetanib—thyroid cancer	0.00349	0.00974	CcSEcCtD
Cyclobenzaprine—Gastritis—Sorafenib—thyroid cancer	0.00341	0.00951	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Vandetanib—thyroid cancer	0.00337	0.00939	CcSEcCtD
Cyclobenzaprine—Vision blurred—Vandetanib—thyroid cancer	0.00324	0.00904	CcSEcCtD
Cyclobenzaprine—Tremor—Vandetanib—thyroid cancer	0.00322	0.00899	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Sorafenib—thyroid cancer	0.00307	0.00855	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Vandetanib—thyroid cancer	0.00302	0.00843	CcSEcCtD
Cyclobenzaprine—Convulsion—Vandetanib—thyroid cancer	0.00298	0.00831	CcSEcCtD
Cyclobenzaprine—Hypertension—Vandetanib—thyroid cancer	0.00297	0.00828	CcSEcCtD
Cyclobenzaprine—Chest pain—Vandetanib—thyroid cancer	0.00293	0.00817	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00293	0.00816	CcSEcCtD
Cyclobenzaprine—Anxiety—Vandetanib—thyroid cancer	0.00292	0.00814	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00291	0.00812	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Sorafenib—thyroid cancer	0.00291	0.00812	CcSEcCtD
Cyclobenzaprine—Bone marrow depression—Epirubicin—thyroid cancer	0.0029	0.0081	CcSEcCtD
Cyclobenzaprine—Stomatitis—Sorafenib—thyroid cancer	0.00289	0.00807	CcSEcCtD
Cyclobenzaprine—Jaundice—Sorafenib—thyroid cancer	0.00289	0.00807	CcSEcCtD
Cyclobenzaprine—Dry mouth—Vandetanib—thyroid cancer	0.00286	0.00799	CcSEcCtD
Cyclobenzaprine—Oedema—Vandetanib—thyroid cancer	0.00281	0.00783	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00275	0.00766	CcSEcCtD
Cyclobenzaprine—Bone marrow depression—Doxorubicin—thyroid cancer	0.00269	0.0075	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00256	0.00713	CcSEcCtD
Cyclobenzaprine—Insomnia—Vandetanib—thyroid cancer	0.00254	0.00708	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Vandetanib—thyroid cancer	0.00252	0.00703	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Vandetanib—thyroid cancer	0.0025	0.00698	CcSEcCtD
Cyclobenzaprine—Tinnitus—Sorafenib—thyroid cancer	0.00248	0.00693	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Vandetanib—thyroid cancer	0.00247	0.00689	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Vandetanib—thyroid cancer	0.00244	0.0068	CcSEcCtD
Cyclobenzaprine—Ageusia—Epirubicin—thyroid cancer	0.00242	0.00675	CcSEcCtD
Cyclobenzaprine—Fatigue—Vandetanib—thyroid cancer	0.00242	0.00675	CcSEcCtD
Cyclobenzaprine—Constipation—Vandetanib—thyroid cancer	0.0024	0.00669	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Sorafenib—thyroid cancer	0.00238	0.00664	CcSEcCtD
Cyclobenzaprine—Alopecia—Sorafenib—thyroid cancer	0.00235	0.00657	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00229	0.0064	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Sorafenib—thyroid cancer	0.00227	0.00634	CcSEcCtD
Cyclobenzaprine—Ageusia—Doxorubicin—thyroid cancer	0.00224	0.00625	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Vandetanib—thyroid cancer	0.00222	0.00619	CcSEcCtD
Cyclobenzaprine—Thinking abnormal—Epirubicin—thyroid cancer	0.00214	0.00597	CcSEcCtD
Cyclobenzaprine—Angioedema—Sorafenib—thyroid cancer	0.00212	0.00591	CcSEcCtD
Cyclobenzaprine—Syncope—Sorafenib—thyroid cancer	0.00208	0.0058	CcSEcCtD
Cyclobenzaprine—Leukopenia—Sorafenib—thyroid cancer	0.00208	0.00579	CcSEcCtD
Cyclobenzaprine—Dysarthria—Epirubicin—thyroid cancer	0.00207	0.00578	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Sorafenib—thyroid cancer	0.00204	0.00569	CcSEcCtD
Cyclobenzaprine—Atrioventricular block—Epirubicin—thyroid cancer	0.00202	0.00564	CcSEcCtD
Cyclobenzaprine—Asthenia—Vandetanib—thyroid cancer	0.00201	0.00562	CcSEcCtD
Cyclobenzaprine—Gait disturbance—Epirubicin—thyroid cancer	0.00201	0.0056	CcSEcCtD
Cyclobenzaprine—Hypertension—Sorafenib—thyroid cancer	0.002	0.00559	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Epirubicin—thyroid cancer	0.002	0.00557	CcSEcCtD
Cyclobenzaprine—Pruritus—Vandetanib—thyroid cancer	0.00199	0.00554	CcSEcCtD
Cyclobenzaprine—Thinking abnormal—Doxorubicin—thyroid cancer	0.00198	0.00553	CcSEcCtD
Cyclobenzaprine—Myalgia—Sorafenib—thyroid cancer	0.00197	0.00551	CcSEcCtD
Cyclobenzaprine—Dry mouth—Sorafenib—thyroid cancer	0.00193	0.00539	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Vandetanib—thyroid cancer	0.00192	0.00536	CcSEcCtD
Cyclobenzaprine—Dysarthria—Doxorubicin—thyroid cancer	0.00192	0.00535	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00189	0.00528	CcSEcCtD
Cyclobenzaprine—Atrioventricular block—Doxorubicin—thyroid cancer	0.00187	0.00522	CcSEcCtD
Cyclobenzaprine—Shock—Sorafenib—thyroid cancer	0.00186	0.0052	CcSEcCtD
Cyclobenzaprine—Gait disturbance—Doxorubicin—thyroid cancer	0.00186	0.00519	CcSEcCtD
Cyclobenzaprine—Dizziness—Vandetanib—thyroid cancer	0.00186	0.00518	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00185	0.00517	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Doxorubicin—thyroid cancer	0.00185	0.00515	CcSEcCtD
Cyclobenzaprine—Anorexia—Sorafenib—thyroid cancer	0.0018	0.00503	CcSEcCtD
Cyclobenzaprine—Vomiting—Vandetanib—thyroid cancer	0.00178	0.00498	CcSEcCtD
Cyclobenzaprine—Rash—Vandetanib—thyroid cancer	0.00177	0.00494	CcSEcCtD
Cyclobenzaprine—Dermatitis—Vandetanib—thyroid cancer	0.00177	0.00493	CcSEcCtD
Cyclobenzaprine—Headache—Vandetanib—thyroid cancer	0.00176	0.0049	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00172	0.00481	CcSEcCtD
Cyclobenzaprine—Hypertonia—Epirubicin—thyroid cancer	0.00172	0.00479	CcSEcCtD
Cyclobenzaprine—Mental disability—Epirubicin—thyroid cancer	0.0017	0.00475	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Sorafenib—thyroid cancer	0.00169	0.00471	CcSEcCtD
Cyclobenzaprine—Nausea—Vandetanib—thyroid cancer	0.00167	0.00465	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Sorafenib—thyroid cancer	0.00167	0.00465	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Sorafenib—thyroid cancer	0.00165	0.00459	CcSEcCtD
Cyclobenzaprine—Fatigue—Sorafenib—thyroid cancer	0.00163	0.00455	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00163	0.00454	CcSEcCtD
Cyclobenzaprine—Constipation—Sorafenib—thyroid cancer	0.00162	0.00452	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Epirubicin—thyroid cancer	0.00159	0.00444	CcSEcCtD
Cyclobenzaprine—Hypertonia—Doxorubicin—thyroid cancer	0.00159	0.00444	CcSEcCtD
Cyclobenzaprine—Mental disability—Doxorubicin—thyroid cancer	0.00157	0.00439	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00155	0.00432	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00151	0.0042	CcSEcCtD
Cyclobenzaprine—Urticaria—Sorafenib—thyroid cancer	0.0015	0.00419	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Sorafenib—thyroid cancer	0.0015	0.00417	CcSEcCtD
Cyclobenzaprine—Purpura—Epirubicin—thyroid cancer	0.00148	0.00412	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Doxorubicin—thyroid cancer	0.00147	0.00411	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00145	0.00405	CcSEcCtD
Cyclobenzaprine—Diplopia—Epirubicin—thyroid cancer	0.00142	0.00397	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Epirubicin—thyroid cancer	0.00142	0.00397	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Sorafenib—thyroid cancer	0.00139	0.00389	CcSEcCtD
Cyclobenzaprine—Face oedema—Epirubicin—thyroid cancer	0.00137	0.00383	CcSEcCtD
Cyclobenzaprine—Purpura—Doxorubicin—thyroid cancer	0.00137	0.00381	CcSEcCtD
Cyclobenzaprine—Asthenia—Sorafenib—thyroid cancer	0.00136	0.00379	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00134	0.00375	CcSEcCtD
Cyclobenzaprine—Pruritus—Sorafenib—thyroid cancer	0.00134	0.00374	CcSEcCtD
Cyclobenzaprine—Ataxia—Epirubicin—thyroid cancer	0.00134	0.00373	CcSEcCtD
Cyclobenzaprine—Diplopia—Doxorubicin—thyroid cancer	0.00132	0.00367	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Doxorubicin—thyroid cancer	0.00132	0.00367	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Sorafenib—thyroid cancer	0.0013	0.00361	CcSEcCtD
Cyclobenzaprine—Face oedema—Doxorubicin—thyroid cancer	0.00127	0.00355	CcSEcCtD
Cyclobenzaprine—Gastritis—Epirubicin—thyroid cancer	0.00126	0.00351	CcSEcCtD
Cyclobenzaprine—Dizziness—Sorafenib—thyroid cancer	0.00125	0.00349	CcSEcCtD
Cyclobenzaprine—Ataxia—Doxorubicin—thyroid cancer	0.00124	0.00345	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Epirubicin—thyroid cancer	0.00122	0.0034	CcSEcCtD
Cyclobenzaprine—Vomiting—Sorafenib—thyroid cancer	0.0012	0.00336	CcSEcCtD
Cyclobenzaprine—Rash—Sorafenib—thyroid cancer	0.00119	0.00333	CcSEcCtD
Cyclobenzaprine—Dermatitis—Sorafenib—thyroid cancer	0.00119	0.00333	CcSEcCtD
Cyclobenzaprine—Headache—Sorafenib—thyroid cancer	0.00119	0.00331	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Epirubicin—thyroid cancer	0.00117	0.00326	CcSEcCtD
Cyclobenzaprine—Gastritis—Doxorubicin—thyroid cancer	0.00117	0.00325	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00114	0.00319	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Epirubicin—thyroid cancer	0.00114	0.00317	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Doxorubicin—thyroid cancer	0.00113	0.00314	CcSEcCtD
Cyclobenzaprine—Nausea—Sorafenib—thyroid cancer	0.00112	0.00314	CcSEcCtD
Cyclobenzaprine—Weight increased—Epirubicin—thyroid cancer	0.00112	0.00312	CcSEcCtD
Cyclobenzaprine—Drowsiness—Epirubicin—thyroid cancer	0.0011	0.00306	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Doxorubicin—thyroid cancer	0.00108	0.00302	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00108	0.003	CcSEcCtD
Cyclobenzaprine—Jaundice—Epirubicin—thyroid cancer	0.00107	0.00298	CcSEcCtD
Cyclobenzaprine—Stomatitis—Epirubicin—thyroid cancer	0.00107	0.00298	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00106	0.00295	CcSEcCtD
Cyclobenzaprine—Sweating—Epirubicin—thyroid cancer	0.00105	0.00293	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Doxorubicin—thyroid cancer	0.00105	0.00293	CcSEcCtD
Cyclobenzaprine—Weight increased—Doxorubicin—thyroid cancer	0.00104	0.00289	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Epirubicin—thyroid cancer	0.00102	0.00286	CcSEcCtD
Cyclobenzaprine—Drowsiness—Doxorubicin—thyroid cancer	0.00101	0.00283	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000995	0.00278	CcSEcCtD
Cyclobenzaprine—Stomatitis—Doxorubicin—thyroid cancer	0.000989	0.00276	CcSEcCtD
Cyclobenzaprine—Jaundice—Doxorubicin—thyroid cancer	0.000989	0.00276	CcSEcCtD
Cyclobenzaprine—Hepatitis—Epirubicin—thyroid cancer	0.000985	0.00275	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Epirubicin—thyroid cancer	0.00098	0.00273	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Epirubicin—thyroid cancer	0.000977	0.00273	CcSEcCtD
Cyclobenzaprine—Sweating—Doxorubicin—thyroid cancer	0.000973	0.00271	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000947	0.00264	CcSEcCtD
Cyclobenzaprine—Tinnitus—Epirubicin—thyroid cancer	0.000918	0.00256	CcSEcCtD
Cyclobenzaprine—Hepatitis—Doxorubicin—thyroid cancer	0.000911	0.00254	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000906	0.00253	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Doxorubicin—thyroid cancer	0.000904	0.00252	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Epirubicin—thyroid cancer	0.00088	0.00245	CcSEcCtD
Cyclobenzaprine—Alopecia—Epirubicin—thyroid cancer	0.00087	0.00243	CcSEcCtD
Cyclobenzaprine—Tinnitus—Doxorubicin—thyroid cancer	0.000849	0.00237	CcSEcCtD
Cyclobenzaprine—Flatulence—Epirubicin—thyroid cancer	0.000845	0.00236	CcSEcCtD
Cyclobenzaprine—Tension—Epirubicin—thyroid cancer	0.000841	0.00235	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Epirubicin—thyroid cancer	0.000839	0.00234	CcSEcCtD
Cyclobenzaprine—Nervousness—Epirubicin—thyroid cancer	0.000832	0.00232	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Doxorubicin—thyroid cancer	0.000814	0.00227	CcSEcCtD
Cyclobenzaprine—Vision blurred—Epirubicin—thyroid cancer	0.000808	0.00225	CcSEcCtD
Cyclobenzaprine—Alopecia—Doxorubicin—thyroid cancer	0.000805	0.00225	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000795	0.00222	CcSEcCtD
Cyclobenzaprine—Agitation—Epirubicin—thyroid cancer	0.000788	0.0022	CcSEcCtD
Cyclobenzaprine—Flatulence—Doxorubicin—thyroid cancer	0.000781	0.00218	CcSEcCtD
Cyclobenzaprine—Tension—Doxorubicin—thyroid cancer	0.000778	0.00217	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Doxorubicin—thyroid cancer	0.000777	0.00217	CcSEcCtD
Cyclobenzaprine—Malaise—Epirubicin—thyroid cancer	0.000773	0.00216	CcSEcCtD
Cyclobenzaprine—Nervousness—Doxorubicin—thyroid cancer	0.00077	0.00215	CcSEcCtD
Cyclobenzaprine—Vertigo—Epirubicin—thyroid cancer	0.00077	0.00215	CcSEcCtD
Cyclobenzaprine—Syncope—Epirubicin—thyroid cancer	0.000769	0.00214	CcSEcCtD
Cyclobenzaprine—Leukopenia—Epirubicin—thyroid cancer	0.000767	0.00214	CcSEcCtD
Cyclobenzaprine—Palpitations—Epirubicin—thyroid cancer	0.000757	0.00211	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Epirubicin—thyroid cancer	0.000753	0.0021	CcSEcCtD
Cyclobenzaprine—Vision blurred—Doxorubicin—thyroid cancer	0.000747	0.00209	CcSEcCtD
Cyclobenzaprine—Convulsion—Epirubicin—thyroid cancer	0.000743	0.00207	CcSEcCtD
Cyclobenzaprine—Hypertension—Epirubicin—thyroid cancer	0.00074	0.00206	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000736	0.00205	CcSEcCtD
Cyclobenzaprine—Myalgia—Epirubicin—thyroid cancer	0.00073	0.00204	CcSEcCtD
Cyclobenzaprine—Chest pain—Epirubicin—thyroid cancer	0.00073	0.00204	CcSEcCtD
Cyclobenzaprine—Agitation—Doxorubicin—thyroid cancer	0.000729	0.00203	CcSEcCtD
Cyclobenzaprine—Anxiety—Epirubicin—thyroid cancer	0.000727	0.00203	CcSEcCtD
Cyclobenzaprine—Discomfort—Epirubicin—thyroid cancer	0.000721	0.00201	CcSEcCtD
Cyclobenzaprine—Malaise—Doxorubicin—thyroid cancer	0.000715	0.002	CcSEcCtD
Cyclobenzaprine—Dry mouth—Epirubicin—thyroid cancer	0.000714	0.00199	CcSEcCtD
Cyclobenzaprine—Vertigo—Doxorubicin—thyroid cancer	0.000713	0.00199	CcSEcCtD
Cyclobenzaprine—Syncope—Doxorubicin—thyroid cancer	0.000711	0.00198	CcSEcCtD
Cyclobenzaprine—Leukopenia—Doxorubicin—thyroid cancer	0.00071	0.00198	CcSEcCtD
Cyclobenzaprine—Confusional state—Epirubicin—thyroid cancer	0.000705	0.00197	CcSEcCtD
Cyclobenzaprine—Palpitations—Doxorubicin—thyroid cancer	0.000701	0.00196	CcSEcCtD
Cyclobenzaprine—Oedema—Epirubicin—thyroid cancer	0.0007	0.00195	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Epirubicin—thyroid cancer	0.0007	0.00195	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000697	0.00194	CcSEcCtD
Cyclobenzaprine—Shock—Epirubicin—thyroid cancer	0.000688	0.00192	CcSEcCtD
Cyclobenzaprine—Convulsion—Doxorubicin—thyroid cancer	0.000687	0.00192	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000685	0.00191	CcSEcCtD
Cyclobenzaprine—Hypertension—Doxorubicin—thyroid cancer	0.000685	0.00191	CcSEcCtD
Cyclobenzaprine—Tachycardia—Epirubicin—thyroid cancer	0.000683	0.0019	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000676	0.00189	CcSEcCtD
Cyclobenzaprine—Chest pain—Doxorubicin—thyroid cancer	0.000675	0.00188	CcSEcCtD
Cyclobenzaprine—Myalgia—Doxorubicin—thyroid cancer	0.000675	0.00188	CcSEcCtD
Cyclobenzaprine—Anxiety—Doxorubicin—thyroid cancer	0.000673	0.00188	CcSEcCtD
Cyclobenzaprine—Discomfort—Doxorubicin—thyroid cancer	0.000667	0.00186	CcSEcCtD
Cyclobenzaprine—Anorexia—Epirubicin—thyroid cancer	0.000667	0.00186	CcSEcCtD
Cyclobenzaprine—Dry mouth—Doxorubicin—thyroid cancer	0.00066	0.00184	CcSEcCtD
Cyclobenzaprine—Hypotension—Epirubicin—thyroid cancer	0.000654	0.00182	CcSEcCtD
Cyclobenzaprine—Confusional state—Doxorubicin—thyroid cancer	0.000653	0.00182	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000647	0.00181	CcSEcCtD
Cyclobenzaprine—Oedema—Doxorubicin—thyroid cancer	0.000647	0.00181	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000637	0.00178	CcSEcCtD
Cyclobenzaprine—Shock—Doxorubicin—thyroid cancer	0.000637	0.00178	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000634	0.00177	CcSEcCtD
Cyclobenzaprine—Insomnia—Epirubicin—thyroid cancer	0.000633	0.00177	CcSEcCtD
Cyclobenzaprine—Tachycardia—Doxorubicin—thyroid cancer	0.000632	0.00176	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Epirubicin—thyroid cancer	0.000628	0.00175	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000626	0.00175	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Epirubicin—thyroid cancer	0.000624	0.00174	CcSEcCtD
Cyclobenzaprine—Somnolence—Epirubicin—thyroid cancer	0.000622	0.00173	CcSEcCtD
Cyclobenzaprine—Anorexia—Doxorubicin—thyroid cancer	0.000617	0.00172	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Epirubicin—thyroid cancer	0.000616	0.00172	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Epirubicin—thyroid cancer	0.000608	0.0017	CcSEcCtD
Cyclobenzaprine—Hypotension—Doxorubicin—thyroid cancer	0.000605	0.00169	CcSEcCtD
Cyclobenzaprine—Fatigue—Epirubicin—thyroid cancer	0.000603	0.00168	CcSEcCtD
Cyclobenzaprine—Constipation—Epirubicin—thyroid cancer	0.000598	0.00167	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00059	0.00165	CcSEcCtD
Cyclobenzaprine—Insomnia—Doxorubicin—thyroid cancer	0.000585	0.00163	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Doxorubicin—thyroid cancer	0.000581	0.00162	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Doxorubicin—thyroid cancer	0.000577	0.00161	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Epirubicin—thyroid cancer	0.000576	0.00161	CcSEcCtD
Cyclobenzaprine—Somnolence—Doxorubicin—thyroid cancer	0.000575	0.00161	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000572	0.0016	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Doxorubicin—thyroid cancer	0.00057	0.00159	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Doxorubicin—thyroid cancer	0.000563	0.00157	CcSEcCtD
Cyclobenzaprine—Fatigue—Doxorubicin—thyroid cancer	0.000558	0.00156	CcSEcCtD
Cyclobenzaprine—Urticaria—Epirubicin—thyroid cancer	0.000556	0.00155	CcSEcCtD
Cyclobenzaprine—Constipation—Doxorubicin—thyroid cancer	0.000553	0.00154	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Epirubicin—thyroid cancer	0.000553	0.00154	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000533	0.00149	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000529	0.00148	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Epirubicin—thyroid cancer	0.000515	0.00144	CcSEcCtD
Cyclobenzaprine—Urticaria—Doxorubicin—thyroid cancer	0.000514	0.00143	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Doxorubicin—thyroid cancer	0.000512	0.00143	CcSEcCtD
Cyclobenzaprine—Asthenia—Epirubicin—thyroid cancer	0.000502	0.0014	CcSEcCtD
Cyclobenzaprine—Pruritus—Epirubicin—thyroid cancer	0.000495	0.00138	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Epirubicin—thyroid cancer	0.000479	0.00134	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000477	0.00133	CcSEcCtD
Cyclobenzaprine—Asthenia—Doxorubicin—thyroid cancer	0.000464	0.0013	CcSEcCtD
Cyclobenzaprine—Dizziness—Epirubicin—thyroid cancer	0.000463	0.00129	CcSEcCtD
Cyclobenzaprine—Pruritus—Doxorubicin—thyroid cancer	0.000458	0.00128	CcSEcCtD
Cyclobenzaprine—Vomiting—Epirubicin—thyroid cancer	0.000445	0.00124	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Doxorubicin—thyroid cancer	0.000443	0.00124	CcSEcCtD
Cyclobenzaprine—Rash—Epirubicin—thyroid cancer	0.000441	0.00123	CcSEcCtD
Cyclobenzaprine—Dermatitis—Epirubicin—thyroid cancer	0.000441	0.00123	CcSEcCtD
Cyclobenzaprine—Headache—Epirubicin—thyroid cancer	0.000438	0.00122	CcSEcCtD
Cyclobenzaprine—Dizziness—Doxorubicin—thyroid cancer	0.000428	0.00119	CcSEcCtD
Cyclobenzaprine—Nausea—Epirubicin—thyroid cancer	0.000416	0.00116	CcSEcCtD
Cyclobenzaprine—Vomiting—Doxorubicin—thyroid cancer	0.000412	0.00115	CcSEcCtD
Cyclobenzaprine—Rash—Doxorubicin—thyroid cancer	0.000408	0.00114	CcSEcCtD
Cyclobenzaprine—Dermatitis—Doxorubicin—thyroid cancer	0.000408	0.00114	CcSEcCtD
Cyclobenzaprine—Headache—Doxorubicin—thyroid cancer	0.000405	0.00113	CcSEcCtD
Cyclobenzaprine—Nausea—Doxorubicin—thyroid cancer	0.000384	0.00107	CcSEcCtD
